Inventor · disambiguated record
Yu Kato
Also filed as: KATO YU
6 granted patents·6 pending applications·9 citations·filing 2015–2024
76Inventor score
Top patents by PatentIndex Score
12 records- 0189US12246097B2Nanoparticle vaccine adjuvant and methods of use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2023·Granted Mar 11, 2025·1 cites·20 claims
- 0287US11547705B2Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancerMERCK SHARP & DOHME LLC·Filed 2016·Granted Jan 10, 2023·4 cites·32 claims
- 0380US11547672B2Nanoparticle vaccine adjuvant and methods of use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted Jan 10, 2023·1 cites·40 claims
- 0477US2025000853A1Combination of a pd-1 antagonist and a vegf-r/fgfr/ret tyrosine kinase inhibitor for treating cancerEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 0574US9527921B2Anti human Notch4 antibodyEISAI R&D MAN CO LTD·Filed 2016·Granted Dec 27, 2016·2 cites·29 claims
- 0672US9969812B2Anti human Notch4 antibodyEISAI R&D MAN CO LTD·Filed 2016·Granted May 15, 2018·1 cites·14 claims
- 0771US12083112B2Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancerMERCK SHARP & DOHME LLC·Filed 2021·Granted Sep 10, 2024·0 cites·21 claims
- 0861US2025177406A1Pharmaceutical composition for treating tumorsEISAI R&D MAN CO LTD·Filed 2023·Application pending·0 cites
- 0957US2024271223A1Biomarkers for a therapy comprising an angiogenesis inhibitorEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 1053US2022409724A1Combination of a pd-1 antagonist, a vegfr/fgfr/ret tyrosine kinase inhibitor and a cbp/beta-catenin inhibitor for treating cancerEISAI R&D MAN CO LTD·Filed 2020·Application pending·0 cites
- 1150US2023330081A1Pharmaceutical composition for treating tumorsEISAI R&D MAN CO LTD·Filed 2021·Application pending·0 cites
- 1238US2016089365A1Immunostimulatory compoundEISAI R&D MAN CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yu Kato files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →